If you’ve ever felt like a human pincushion during a blood test, your salvation may have arrived. Vitestro’s Aletta, an autonomous phlebotomy robot, just snagged FDA authorization after a clinical trial proved it can achieve a 94.5% first-stick success rate—even on patients with difficult veins. Using a combination of near-infrared and ultrasound imaging, this AI-powered device is officially more reliable than some of its human counterparts, and a single supervisor can oversee three of them at once. The unemployment line for phlebotomists just got a little longer.
